DEVA Holdings NZ Ltd has been awarded sole supply of Ceftriaxone as of September 2016 for two strenghts, 0.5 g and 1. In addition, DEVA Holdings NZ Ltd is currently supplying the product from DEVA Holding A.S. in Turkey.

DEVA Holdings NZ Ltd has been awarded sole supply of pramipexole as of June 2015 for two strenghts, 0.25 mg and 1.0 mg under its brand Ramipex. In addition, DEVA Holdings NZ Ltd is currently supplying the product from DEVA Holding A.S. in Turkey.

DEVA Holding A.S. will be attending CPhl Worldwide in Madrid between 13-15 October 2015. The event will host 2500+ exhibitors and is expected to attract more than 30,000 visitors. You can visit DEVA Holding at booth 10H30 during this grand meeting.

DEVA Holdings NZ Ltd has been awarded sole supply of pramipexole as of August 2014 for two strenghts, 0.25 mg and 1.0 mg under its brand Ramipex. In addition, DEVA Holdings NZ Ltd is already now supplying the product from DEVA Holding A.S. in Turkey under article 29. Both products are exactly identical and either can be used.